S 4013 New Jersey Senate · 2024-2025 Regular Session

Permits clinical laboratories to provide certain patients discounts without affecting NJ FamilyCare reimbursement rates or violating NJ Familycare rebate prohibitions.

S 4013 allows New Jersey clinical laboratories to offer discounts to patients facing financial hardship without reducing their NJ FamilyCare reimbursement rates or violating anti-rebate regulations. The bill permits labs to charge uninsured, underinsured, or vulnerable patients (including those experiencing homelessness, extreme poverty, awaiting Medicaid enrollment, or required for substance use disorder testing) less for services while maintaining standard reimbursement rates from NJ FamilyCare. To qualify for a discount, patients must demonstrate financial hardship through income documentation or evidence of exceptional circumstances. The bill also requires dismissal of pending enforcement actions against labs for previously offering such discounts, ensuring these discounts won't be considered violations of anti-rebate rules. This change aims to improve access to laboratory services for vulnerable populations without penalizing providers for offering financial assistance.
Sub-Topics: Substance Abuse
Bill status in committee 1 of 4 stages cleared
Introduction
Jan 2025
Committee Review
Floor Vote
Governor
Introduced Jan 14, 2025 Last action Jan 14, 2025
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
1
Key actions
0
Committee
0
Jan 14, 2025
Introduced
Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee
upper
1 primary · 1 co-sponsor

Sponsors